The positron emission tomography (PET) scanners market is estimated to be valued at US$ 1.3 billion in 2023 and is rising to US$ 2.1 billion by 2033. The market is likely to grow at a CAGR of 5.3% during the forecast period. Various factors driving the market for positron emission tomography (PET) scanners are:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Although the efficacy of PET scanners has been established, continuous reimbursement cutbacks are affecting the market's growth. Players have been declined reimbursement for these products worldwide, which has resulted in a reduced number for outpatient volume, thus affecting access to high-quality and cost-effective diagnostic imaging services.
Apart from this, radiopharmaceuticals used during PET scanning procedures have a short life. The systems utilize radioisotope tracers to gain better imaging capabilities, thus providing more specific information about organ function or dysfunction.
The most common radiotracer is fluorodeoxyglucose (FDG), which incorporates fluorine-18 as a tracer. It is the most used radiotracer in PET scanning and imaging. However, the radiotracer has a half-life of just under 2 hours, limiting its utility.
The growing adoption of PET and X-ray transmission computed tomography (CT) scans is expected to boost the market in the forthcoming years. This innovative technology reduces acquisition time and provides precise attenuation correction and fusion imaging, resulting in high diagnostic sensitivity and specificity.
Moreover, the combination of PET and CT helps in the better staging of disease by defining prognostic and treatment monitoring capabilities of the functional and metabolic information given by conventional nuclear imaging techniques. Most PET scanning procedures use fluorodeoxyglucose (FDG) as it can capture tissue glucose metabolism and increase its parameters. However, fluorodeoxyglucose has a few shortcomings, such as low specificity.
Additionally, several potential radiotracers are under investigation to address the unmet clinical needs of diagnosis of diseases. In response, manufacturers are launching new products with higher sensitivity regarding metabolic activity to achieve detailed scans. Players are also investing in mergers and acquisitions to improve their product portfolios.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 5.3% |
| Market Valuation (2023) | US$ 1.3 billion |
| Market Valuation (2033) | US$ 2.1 billion |
Principal Consultant
Future Market Insights projects the global emission tomography (PET) scanners market to expand at a healthy 5.3% CAGR during the forecast period. Historically, the market registered a CAGR of 4.6% between 2017 and 2022.
Short Term (2022 to 2025): Increasing demand for radiopharmaceuticals, integrating computed tomography with PET, and advancements in hybrid imaging systems boost the market expansion.
Medium Term (2025 to 2028): PET scanners employ a type of nuclear medicine process to measure the metabolic activity of the body tissues and cells. They are mostly used in patients with heart or brain conditions and cancer. The process involves visualization of biochemical changes in the body, such as the metabolism of the heart muscle.
Long Term (2028 to 2033): PET scanners are widely adopted due to their ability to visualize and quantify tumoral features on molecular levels, compared to traditional techniques. Rising awareness regarding the advantages of radiotherapy and radiation oncology and a growing disposition towards non-invasive procedures are driving market opportunities.
The market is estimated to reach US$ 2.1 billion during the forecast period. In the historical period, the market stood at a valuation of US$ 1.2 billion from 2017 to 2022.
| Segments | Product Type |
|---|---|
| Top Category | Full-ring PET Scanner |
| Historic CAGR | 4.7% |
| Forecast CAGR | 5.2% |
| Segments | Application |
|---|---|
| Top Category | Oncology |
| Historic CAGR | 4.1% |
| Forecast CAGR | 4.9% |
Based on product type, demand for full-ring PET scanners is projected to surge at a CAGR of 5.2% during the forecast period. The product offers high efficiency and contains multiple rings of scintillator detectors. These detectors cover a full 360-degree angular rotation around the volume to be imaged. Historically, the full-ring PET scanner secured a CAGR of 4.7% between 2017 and 2022.
In terms of applications, the oncology segment dominates the global market by securing a CAGR of 4.9% during the forecast period. The adoption of PET scanners in oncology for imaging techniques is growing the market share.
The rising demand for PET scanner in clinical trials to determine therapeutic response for novel cancer are increasing the market expansion. Historically, the oncology segment captured a CAGR of 4.1% between 2017 to 2022.
Based on the detector type, sales of lutetium oxyorthosilicate (LSO) led to more than 37.3% of the total market share in 2020. The lutetium oxyorthosilicate (LSO) segment is expected to grow at a 7.0% CAGR over the assessment period.
Based on end users, hospitals and diagnostic centers held more than 60% of the total market share in 2020. Sales in these segments are expected to grow on the back of an increasing number of diagnostic centers installed with PET imaging machines.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The USA |
|---|---|
| CAGR (2017 to 2022) | 4.9% |
| CAGR (2023 to 2023) | 5.4% |
| Valuation (2023 to 2033) | US$ 876.0 million |
| County | The United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 3.5% |
| CAGR (2023 to 2023) | 4.0% |
| Valuation (2023 to 2033) | US$ 41.0 million |
| Country | Germany |
|---|---|
| CAGR (2017 to 2022) | 3.4% |
| CAGR (2023 to 2023) | 4.1% |
| Valuation (2023 to 2033) | US$ 54.7 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 6% |
| CAGR (2023 to 2023) | 6.6% |
| Valuation (2023 to 2033) | US$ 98.9 million |
| Country | India |
|---|---|
| CAGR (2017 to 2022) | 5.4% |
| CAGR (2023 to 2023) | 4.8% |
| Valuation (2023 to 2033) | US$ 70.7 million |
The USA is expected to dominate the North American market, securing a CAGR of 5.4% with a valuation of US$ 876.0 million during the forecast period. The rising prevalence of cancer in the country underpins the need for advanced PET scanners, thereby creating sales prospects in the market.
According to the National Cancer Institute, in 2020, an estimated 1,806,590 new cancer cases were expected to be diagnosed in the United States, and 606,520 people were expected to die from the disease. The rate of new cases of cancer (cancer incidence) is 442.4 per 100,000 men and women per year (based on 2013 to 2017 cases), as per the National Cancer Institute. Therefore, this is expected to boost The USA positron emission tomography (PET) scanners market during the forecast period. Historically, the USA market secured a CAGR of 4.9% between 2017 and 2022.
China is capturing a CAGR of 6.6% with a valuation of US$ 98.9 million during the forecast period. Increasing efforts by manufacturers to incorporate value-based detectors in their PET machines are expected to drive sales in China.
The increasing adoption of LFS scintillation crystals for a new line of PET scanners is expected to boost the Chinese positron emission tomography (PET) scanners market. Historically, the China market secured a CAGR of 6% between 2017 and 2022.
India is capturing a CAGR of 4.8% with a valuation of US$ 70.7 million during the forecast period. The country's widespread technology diffusion drives the demand for positron emission tomography (PET) scanners. Also, the increasing number of PET scanning facilities in India is expected to continue boosting their installation over the assessment period.
The present key players, advanced technology in the healthcare sector, and growing investment are driving the Indian positron emission tomography (PET) scanners market. Historically, the Indian market secured a CAGR of 5.4% between 2017 and 2022.
Key players focus on novel and innovative approaches to develop positron emission tomography scanners. Production facility expansions, new product launches, and product approvals can strengthen their market presence
Some of the prominent players in the market are:
Recent Developments in the Positron Emission Tomography (PET) Scanners Market
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | The USA, Canada, Germany, The United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Segments Covered | Product Type, Application, Detector Type, End User, Region |
| Key Companies Profiled | GE Healthcare; Toshiba Corporation; Koninklijke Philips N.V.; Siemens Healthineers; Hitachi Medical Corporation; Positron Corporation; Mediso Ltd.; Yangzhou Kindsway Biotech Co.Ltd |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
As of 2023, the PET scanners market holds a valuation of about US$ 1.3 billion.
The PET scanners market is projected to attain a value of US$ 2.1 billion by 2033, driven by a CAGR of 5.3% between 2023 and 2033.
Innovative niches within the PET scanners market include hybrid imaging systems, compact mobile units, and AI-powered image analysis advancements.
With a projected market revenue of US$ 876.0 million by 2033, the United States exerts primary control over the PET scanners market.
Integrated AI diagnostics and improved radioisotope availability are driving trends shaping the PET scanners market landscape.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Full-ring PET Scanner
5.3.2. Partial-ring PET Scanner
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Oncology
6.3.2. Cardiology
6.3.3. Neurology
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Detector Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) Analysis By Detector Type, 2017 to 2022
7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Detector Type, 2023 to 2033
7.3.1. Bismuth Germanium Oxide
7.3.2. Lutetium Oxyorthosilicate
7.3.3. Gadolinium Oxyorthosilicate
7.3.4. Lutetium Fine Silicate
7.3.5. Lutetium Yttrium Orthosilicate
7.4. Y-o-Y Growth Trend Analysis By Detector Type, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Detector Type, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022
8.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. PET Centers
8.3.4. Research Institute
8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. Asia Pacific excluding Japan(APEJ)
9.3.6. Japan
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By Detector Type
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By Detector Type
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By Detector Type
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By Detector Type
11.3.5. By End User
11.4. Key Takeaways
12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. The United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Nordic countries
12.2.1.7. BENELUX
12.2.1.8. Rest Of Western Europe
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By Detector Type
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By Detector Type
12.3.5. By End User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Russia
13.2.1.2. Poland
13.2.1.3. Rest Of Eastern Europe
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By Detector Type
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By Detector Type
13.3.5. By End User
13.4. Key Takeaways
14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. India
14.2.1.3. ASEAN
14.2.1.4. Australia & New Zealand
14.2.2. By Product Type
14.2.3. By Application
14.2.4. By Detector Type
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By Detector Type
14.3.5. By End User
14.4. Key Takeaways
15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.2. By Product Type
15.2.3. By Application
15.2.4. By Detector Type
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By Detector Type
15.3.5. By End User
15.4. Key Takeaways
16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
16.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest Of MEA
16.2.2. By Product Type
16.2.3. By Application
16.2.4. By Detector Type
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Application
16.3.4. By Detector Type
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. The USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product Type
17.1.2.2. By Application
17.1.2.3. By Detector Type
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product Type
17.2.2.2. By Application
17.2.2.3. By Detector Type
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product Type
17.3.2.2. By Application
17.3.2.3. By Detector Type
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product Type
17.4.2.2. By Application
17.4.2.3. By Detector Type
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product Type
17.5.2.2. By Application
17.5.2.3. By Detector Type
17.5.2.4. By End User
17.6. The United Kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product Type
17.6.2.2. By Application
17.6.2.3. By Detector Type
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product Type
17.7.2.2. By Application
17.7.2.3. By Detector Type
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product Type
17.8.2.2. By Application
17.8.2.3. By Detector Type
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product Type
17.9.2.2. By Application
17.9.2.3. By Detector Type
17.9.2.4. By End User
17.10. Nordic countries
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product Type
17.10.2.2. By Application
17.10.2.3. By Detector Type
17.10.2.4. By End User
17.11. BENELUX
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product Type
17.11.2.2. By Application
17.11.2.3. By Detector Type
17.11.2.4. By End User
17.12. Russia
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product Type
17.12.2.2. By Application
17.12.2.3. By Detector Type
17.12.2.4. By End User
17.13. Poland
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product Type
17.13.2.2. By Application
17.13.2.3. By Detector Type
17.13.2.4. By End User
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product Type
17.14.2.2. By Application
17.14.2.3. By Detector Type
17.14.2.4. By End User
17.15. India
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product Type
17.15.2.2. By Application
17.15.2.3. By Detector Type
17.15.2.4. By End User
17.16. ASEAN
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product Type
17.16.2.2. By Application
17.16.2.3. By Detector Type
17.16.2.4. By End User
17.17. Australia & New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product Type
17.17.2.2. By Application
17.17.2.3. By Detector Type
17.17.2.4. By End User
17.18. Japan
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product Type
17.18.2.2. By Application
17.18.2.3. By Detector Type
17.18.2.4. By End User
17.19. GCC countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product Type
17.19.2.2. By Application
17.19.2.3. By Detector Type
17.19.2.4. By End User
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product Type
17.20.2.2. By Application
17.20.2.3. By Detector Type
17.20.2.4. By End User
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Product Type
17.21.2.2. By Application
17.21.2.3. By Detector Type
17.21.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product Type
18.3.3. By Application
18.3.4. By Detector Type
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. GE Healthcare
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Toshiba Corporation
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Koninklijke Philips N.V.
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Siemens Healthineers
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Hitachi Medical Corporation
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Positron Corporation
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Mediso Ltd.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Yangzhou Kindsway Biotech Co.Ltd
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Oncovision
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Canon Medical Systems Corporation
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Positron Emission Tomography (PET) Scanners Market
